Condition: Methamphetamine Intoxication · Methamphetamine Disorders · Methamphetamine Abuse · Sponsor: Clear Scientific, Inc.
The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disorder in the presence of a clinically relevant dose of methamphetamine HCl (30 mg IV).
This description comes directly from the study's public registry record.
Anna Del Rosario, B.S. · 617-621-8500 · adelrosario@clearsci.com
Piercen Oliver, Ph.D. · 617-621-8500 · poliver@clearsci.com
Always discuss trial participation with your own doctor first.
| California Clinical Trials Medical Group | Glendale, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06721494